{"count": 15, "results": [{"_id": "34439890", "pmid": 34439890, "pmcid": "PMC8391370", "title": "Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus", "journal": "Biomolecules", "authors": ["Tseng CH"], "date": "2021-08-17T00:00:00Z", "doi": "10.3390/biom11081226", "meta_date_publication": "2021 Aug 17", "meta_volume": "11", "meta_issue": "8", "meta_pages": "", "score": 50274.59, "text_hl": "...The risk of @<m>DISEASE_Brain_Neoplasms</m> @DISEASE_MESH:D001932 @@@malignant brain tumors@@@ associated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use has rarely been investigated in @SPECIES_9606 @@@humans@@@. ", "citations": {"NLM": "Tseng CH. Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus Biomolecules. 2021 Aug 17;11(8):. PMID: 34439890", "BibTeX": "@article{34439890, title={Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus}, author={Tseng CH}, journal={Biomolecules}, volume={11}, number={8}}"}}, {"_id": "33869859", "pmid": 33869859, "pmcid": "PMC8044986", "title": "The potential of metformin as an antineoplastic in brain tumors: A systematic review", "journal": "Heliyon", "authors": ["Takhwifa F", "Aninditha T", "Setiawan H", "Sauriasari R"], "date": "2021-04-08T00:00:00Z", "doi": "10.1016/j.heliyon.2021.e06558", "meta_date_publication": "2021 Apr", "meta_volume": "7", "meta_issue": "4", "meta_pages": "e06558", "score": 50272.246, "text_hl": "The potential of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as an antineoplastic in @<m>DISEASE_Brain_Neoplasms</m> @DISEASE_MESH:D001932 @@@brain tumors@@@: A systematic review", "citations": {"NLM": "Takhwifa F, Aninditha T, Setiawan H, Sauriasari R. The potential of metformin as an antineoplastic in brain tumors: A systematic review Heliyon. 2021 Apr;7(4):e06558. PMID: 33869859", "BibTeX": "@article{33869859, title={The potential of metformin as an antineoplastic in brain tumors: A systematic review}, author={Takhwifa F and Aninditha T and Setiawan H and Sauriasari R}, journal={Heliyon}, volume={7}, number={4}, pages={e06558}}"}}, {"_id": "40515500", "pmid": 40515500, "title": "Repairing Myelin After Irradiated Pediatric Brain Tumor: A Magnetization Transfer Imaging Analysis.", "journal": "Pediatr Blood Cancer", "authors": ["Baudou É", "Ryan JL", "Tseng J", "Bouffet É", "Bartels U", "Timmons BW", "de Medeiros CB", "Mabbott DJ"], "date": "2025-06-14T00:00:00Z", "doi": "10.1002/pbc.31838", "meta_date_publication": "2025 Jun 14", "meta_volume": "", "meta_issue": "", "meta_pages": "e31838", "score": 50261.477, "text_hl": "BACKGROUND: While exercise training and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment have demonstrated preliminary cognitive improvements in pediatric @<m>DISEASE_Brain_Neoplasms</m> @DISEASE_MESH:D001932 @@@brain tumor@@@ (PBT) survivors, the neuronal mechanisms underlying their cognitive improvements are unclear. ", "citations": {"NLM": "Baudou É, Ryan JL, Tseng J, Bouffet É, Bartels U, Timmons BW, de Medeiros CB, Mabbott DJ. Repairing Myelin After Irradiated Pediatric Brain Tumor: A Magnetization Transfer Imaging Analysis. Pediatr Blood Cancer. 2025 Jun 14;():e31838. PMID: 40515500", "BibTeX": "@article{40515500, title={Repairing Myelin After Irradiated Pediatric Brain Tumor: A Magnetization Transfer Imaging Analysis.}, author={Baudou É and Ryan JL and Tseng J and Bouffet É and Bartels U and Timmons BW and de Medeiros CB and Mabbott DJ}, journal={Pediatr Blood Cancer}, pages={e31838}}"}}, {"_id": "32719487", "pmid": 32719487, "title": "Assessment of cognitive and neural recovery in survivors of pediatric brain tumors in a pilot clinical trial using metformin.", "journal": "Nat Med", "authors": ["Ayoub R", "Ruddy RM", "Cox E", "Oyefiade A", "Derkach D", "Laughlin S", "Ades-Aron B", "Shirzadi Z", "Fieremans E", "MacIntosh BJ", "de Medeiros CB", "Skocic J", "Bouffet E", "Miller FD", "Morshead CM", "Mabbott DJ"], "date": "2020-08-01T00:00:00Z", "doi": "10.1038/s41591-020-0985-2", "meta_date_publication": "2020 Aug", "meta_volume": "26", "meta_issue": "8", "meta_pages": "1285-1294", "score": 50260.535, "text_hl": "Assessment of cognitive and neural recovery in survivors of pediatric @<m>DISEASE_Brain_Neoplasms</m> @DISEASE_MESH:D001932 @@@brain tumors@@@ in a pilot clinical trial using @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Ayoub R, Ruddy RM, Cox E, Oyefiade A, Derkach D, Laughlin S, Ades-Aron B, Shirzadi Z, Fieremans E, MacIntosh BJ, de Medeiros CB, Skocic J, Bouffet E, Miller FD, Morshead CM, Mabbott DJ. Assessment of cognitive and neural recovery in survivors of pediatric brain tumors in a pilot clinical trial using metformin. Nat Med. 2020 Aug;26(8):1285-1294. PMID: 32719487", "BibTeX": "@article{32719487, title={Assessment of cognitive and neural recovery in survivors of pediatric brain tumors in a pilot clinical trial using metformin.}, author={Ayoub R and Ruddy RM and Cox E and Oyefiade A and Derkach D and Laughlin S and Ades-Aron B and Shirzadi Z and Fieremans E and MacIntosh BJ and de Medeiros CB and Skocic J and Bouffet E and Miller FD and Morshead CM and Mabbott DJ}, journal={Nat Med}, volume={26}, number={8}, pages={1285-1294}}"}}, {"_id": "33713207", "pmid": 33713207, "pmcid": "PMC8134278", "title": "The prevalence of secondary neoplasms in acromegalic patients: possible preventive and/or protective role of metformin", "journal": "Int J Clin Oncol", "authors": ["Costa D", "Ceccato F", "Lauretta R", "Mercuri V", "D'Amico T", "De Vito C", "Scaroni C", "Appetecchia M", "Gargiulo P"], "date": "2021-06-01T00:00:00Z", "doi": "10.1007/s10147-021-01895-y", "meta_date_publication": "2021 Jun", "meta_volume": "26", "meta_issue": "6", "meta_pages": "1015-1021", "score": 50254.855, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ could act directly on @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ cell metabolism and may have an adjuvant role in @<m>DISEASE_Brain_Neoplasms</m> @DISEASE_MESH:D001932 @@@benign lesion@@@ progression.", "citations": {"NLM": "Costa D, Ceccato F, Lauretta R, Mercuri V, D'Amico T, De Vito C, Scaroni C, Appetecchia M, Gargiulo P. The prevalence of secondary neoplasms in acromegalic patients: possible preventive and/or protective role of metformin Int J Clin Oncol. 2021 Jun;26(6):1015-1021. PMID: 33713207", "BibTeX": "@article{33713207, title={The prevalence of secondary neoplasms in acromegalic patients: possible preventive and/or protective role of metformin}, author={Costa D and Ceccato F and Lauretta R and Mercuri V and D'Amico T and De Vito C and Scaroni C and Appetecchia M and Gargiulo P}, journal={Int J Clin Oncol}, volume={26}, number={6}, pages={1015-1021}}"}}, {"_id": "38415699", "pmid": 38415699, "title": "Factors associated with longer survival among older medicare patients after diagnosis of supratentorial primary brain malignancies: a retrospective cohort study.", "journal": "Neurol Res", "authors": ["Nguyen AV", "Soto JM", "Digbeu BD", "Nguyen CY", "Wu E", "Huang JH", "Kuo YF"], "date": "2024-02-28T00:00:00Z", "doi": "10.1080/01616412.2024.2323335", "meta_date_publication": "2024 Feb 28", "meta_volume": "", "meta_issue": "", "meta_pages": "1-12", "score": 50253.22, "text_hl": "DISCUSSION: Our study suggests that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, beta-blockers, ACEIs, ARBs, and comorbid @DISEASE_Parkinson_Disease @DISEASE_MESH:D010300 @@@PD@@@ are associated with a survival benefit among geriatric Medicare @SPECIES_9606 @@@patients@@@ with supratentorial @<m>DISEASE_Brain_Neoplasms</m> @DISEASE_MESH:D001932 @@@PMBTs@@@.", "citations": {"NLM": "Nguyen AV, Soto JM, Digbeu BD, Nguyen CY, Wu E, Huang JH, Kuo YF. Factors associated with longer survival among older medicare patients after diagnosis of supratentorial primary brain malignancies: a retrospective cohort study. Neurol Res. 2024 Feb 28;():1-12. PMID: 38415699", "BibTeX": "@article{38415699, title={Factors associated with longer survival among older medicare patients after diagnosis of supratentorial primary brain malignancies: a retrospective cohort study.}, author={Nguyen AV and Soto JM and Digbeu BD and Nguyen CY and Wu E and Huang JH and Kuo YF}, journal={Neurol Res}, pages={1-12}}"}}, {"_id": "34680039", "pmid": 34680039, "pmcid": "PMC8533555", "title": "Metformin Is Associated with a Lower Incidence of Benign Brain Tumors: A Retrospective Cohort Study in Patients with Type 2 Diabetes Mellitus", "journal": "Biomolecules", "authors": ["Tseng CH"], "date": "2021-09-25T00:00:00Z", "doi": "10.3390/biom11101405", "meta_date_publication": "2021 Sep 25", "meta_volume": "11", "meta_issue": "10", "meta_pages": "", "score": 50251.58, "text_hl": "Background: The risk of @<m>DISEASE_Brain_Neoplasms</m> @DISEASE_MESH:D001932 @@@benign brain tumors@@@ (@<m>DISEASE_Brain_Neoplasms</m> @DISEASE_MESH:D001932 @@@BBT@@@) associated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use has not received much attention. ", "citations": {"NLM": "Tseng CH. Metformin Is Associated with a Lower Incidence of Benign Brain Tumors: A Retrospective Cohort Study in Patients with Type 2 Diabetes Mellitus Biomolecules. 2021 Sep 25;11(10):. PMID: 34680039", "BibTeX": "@article{34680039, title={Metformin Is Associated with a Lower Incidence of Benign Brain Tumors: A Retrospective Cohort Study in Patients with Type 2 Diabetes Mellitus}, author={Tseng CH}, journal={Biomolecules}, volume={11}, number={10}}"}}, {"_id": "37295189", "pmid": 37295189, "title": "Development and validation of a GC-MS method for determination of metformin in normal brain and in glioblastoma tissues.", "journal": "J Pharm Biomed Anal", "authors": ["Ailuno G", "Baldassari S", "Balboni A", "Drava G", "Spalletti C", "Tantillo E", "Mazzanti M", "Barbieri F", "Thellung S", "Florio T", "Caviglioli G"], "date": "2023-06-02T00:00:00Z", "doi": "10.1016/j.jpba.2023.115503", "meta_date_publication": "2023 Jun 2", "meta_volume": "234", "meta_issue": "", "meta_pages": "115503", "score": 50245.305, "text_hl": "This analytical method can be usefully applied in preclinical studies aiming at clarifying @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MH@@@ mechanism of action in @<m>DISEASE_Brain_Neoplasms</m> @DISEASE_MESH:D001932 @@@brain tumors@@@.", "citations": {"NLM": "Ailuno G, Baldassari S, Balboni A, Drava G, Spalletti C, Tantillo E, Mazzanti M, Barbieri F, Thellung S, Florio T, Caviglioli G. Development and validation of a GC-MS method for determination of metformin in normal brain and in glioblastoma tissues. J Pharm Biomed Anal. 2023 Jun 2;234():115503. PMID: 37295189", "BibTeX": "@article{37295189, title={Development and validation of a GC-MS method for determination of metformin in normal brain and in glioblastoma tissues.}, author={Ailuno G and Baldassari S and Balboni A and Drava G and Spalletti C and Tantillo E and Mazzanti M and Barbieri F and Thellung S and Florio T and Caviglioli G}, journal={J Pharm Biomed Anal}, volume={234}, pages={115503}}"}}, {"_id": "33575655", "pmid": 33575655, "pmcid": "PMC7865080", "title": "Clinical, molecular, metabolic, and immune features associated with oxidative phosphorylation in melanoma brain metastases", "journal": "Neurooncol Adv", "authors": ["Fischer GM", "Guerrieri RA", "Hu Q", "Joon AY", "Kumar S", "Haydu LE", "McQuade JL", "Vashisht Gopal YN", "Knighton B", "Deng W", "Hudgens CW", "Lazar AJ", "Tetzlaff MT", "Davies MA"], "date": "2021-01-06T00:00:00Z", "doi": "10.1093/noajnl/vdaa177", "meta_date_publication": "2021 Jan-Dec", "meta_volume": "3", "meta_issue": "1", "meta_pages": "vdaa177", "score": 50237.72, "text_hl": "High-OXPHOS @<m>DISEASE_Brain_Neoplasms</m> @DISEASE_MESH:D001932 @@@MBMs@@@ also exhibited a transcriptional signature of deficient immune activation, which was reversed in @CELLLINE_CVCL:0159 @@@B16-F10@@@ @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@intracranial tumors@@@ with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment, an OXPHOS inhibitor.", "citations": {"NLM": "Fischer GM, Guerrieri RA, Hu Q, Joon AY, Kumar S, Haydu LE, McQuade JL, Vashisht Gopal YN, Knighton B, Deng W, Hudgens CW, Lazar AJ, Tetzlaff MT, Davies MA. Clinical, molecular, metabolic, and immune features associated with oxidative phosphorylation in melanoma brain metastases Neurooncol Adv. 2021 Jan-Dec;3(1):vdaa177. PMID: 33575655", "BibTeX": "@article{33575655, title={Clinical, molecular, metabolic, and immune features associated with oxidative phosphorylation in melanoma brain metastases}, author={Fischer GM and Guerrieri RA and Hu Q and Joon AY and Kumar S and Haydu LE and McQuade JL and Vashisht Gopal YN and Knighton B and Deng W and Hudgens CW and Lazar AJ and Tetzlaff MT and Davies MA}, journal={Neurooncol Adv}, volume={3}, number={1}, pages={vdaa177}}"}}, {"_id": "28030813", "pmid": 28030813, "pmcid": "PMC5352398", "title": "Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation", "journal": "Oncotarget", "authors": ["Leidgens V", "Proske J", "Rauer L", "Moeckel S", "Renner K", "Bogdahn U", "Riemenschneider MJ", "Proescholdt M", "Vollmann-Zwerenz A", "Hau P", "Seliger C"], "date": "2017-01-31T00:00:00Z", "doi": "10.18632/oncotarget.14159", "meta_date_publication": "2017 Jan 31", "meta_volume": "8", "meta_issue": "5", "meta_pages": "8250-8263", "score": 50057.19, "text_hl": "@CHEMICAL_stattic @CHEMICAL_MESH:C517409 @@@Stattic@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ inhibit @<m>DISEASE_Brain_Neoplasms</m> @DISEASE_MESH:D001932 @@@brain tumor@@@ initiating cells by reducing @GENE_STAT3 @GENE_6774 @@@STAT3@@@-phosphorylation", "citations": {"NLM": "Leidgens V, Proske J, Rauer L, Moeckel S, Renner K, Bogdahn U, Riemenschneider MJ, Proescholdt M, Vollmann-Zwerenz A, Hau P, Seliger C. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation Oncotarget. 2017 Jan 31;8(5):8250-8263. PMID: 28030813", "BibTeX": "@article{28030813, title={Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation}, author={Leidgens V and Proske J and Rauer L and Moeckel S and Renner K and Bogdahn U and Riemenschneider MJ and Proescholdt M and Vollmann-Zwerenz A and Hau P and Seliger C}, journal={Oncotarget}, volume={8}, number={5}, pages={8250-8263}}"}}]}